NCT06698172

Brief Summary

Acquired brain injury" refers to brain damage that impacts neurological processing, making daily activities challenging and often causing vision issues like binocular dysfunction, oculomotor problems, and visual field loss. In Spain, visual rehabilitation is limited, although it is more common in other countries. These patients generally need an interdisciplinary approach involving professionals like physiotherapists and optometrists and often face mobility, balance, and spatial perception difficulties. Treatment tools include lenses, prisms, and technologies like virtual reality (VR). The Visionary VR program, presented by Dr. Portela, has shown promising results in visual field recovery by stimulating the affected area. Visual rehabilitation is based on brain plasticity and involves three key strategies: Prisms to expand the visual field. Compensatory therapy to improve eye movement. Restitution therapy to restore the visual field.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

November 29, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

November 20, 2024

Status Verified

October 1, 2024

Enrollment Period

11 months

First QC Date

November 11, 2024

Last Update Submit

November 18, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual field

    The threshold test will be used in a 30-2 field size with fixation monitoring.

    15 minutes

  • Balance

    The stabilometric study will be conducted using the Podoprint® pressure platform (Grupo Namrol, Barcelona, Spain). A balance assessment will be conducted after 6 sessions and after 12 sessions of treatment.

    15 minutes

Secondary Outcomes (16)

  • Visual Acuity

    2 minutes

  • Subjective refraction

    5 minutes

  • Worth test

    1 minute

  • Ramdom Dot 2

    2 minutes

  • Cover Test

    1 minute

  • +11 more secondary outcomes

Study Arms (1)

VR Study Group

EXPERIMENTAL

Once the patient is included in the study, 12 weekly sessions of visual rehabilitation, each lasting 45 minutes, will be scheduled. A Virtual Reality device will be used along with the Visionary Sport visual therapy software.

Other: Virtual Reality rehabilitation

Interventions

The study includes 12 weekly 45-minute visual rehabilitation sessions using a Virtual Reality device with Visionary Sport software. Originally designed for sports visual training, this software features gamified exercises to improve visual response times under professional supervision. Activities include games to enhance fixation, ocular motility, peripheral vision, and vergence. The "Peripheral Attention" activity trains reaction times to static stimuli perceived in the peripheral retina, adjustable to the patient's visual field defect. Stimuli can be placed at 10, 20, or 30 degrees in the peripheral field. The VR headset (Vive Focus 3) includes an eye tracker to monitor and adapt stimuli based on patient performance. Patients also perform 30 minutes of daily exercises at home, using proprietary software and Tobii 4C and 5C eye-tracking devices for ocular monitoring.

VR Study Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subjects diagnosed with acquired brain injury either from a stroke or trauma.
  • Subjects without cognitive impairment.
  • Subjects without pre-existing musculoskeletal disorders prior to the acquired brain injury.
  • Subjects without hemineglect.
  • Subjects with more than 6 months of progression since the brain injury.
  • Subjects who have an electronic device such as a computer and internet access to perform the exercises at home.
  • Subjects with altitudinal visual field loss, hemianopia, or quadrantanopia with the central field preserved and at least 0.5 visual acuity.

You may not qualify if:

  • Not signing the informed consent.
  • Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
  • Uncontrolled epilepsy.
  • Subjects with glaucoma or retinal pathologies affecting the visual field.
  • Subjects with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
  • Subjects who are not stable in any associated clinical pathology or otherwise diagnosed.
  • Subjects who have previously undergone visual rehabilitation for the field defect.
  • Not performing the proposed home exercises.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Zaragoza

Zaragoza, Zaragoza, 50009, Spain

RECRUITING

University of Zaragoza

Zaragoza, Zaragoza, 50009, Spain

RECRUITING

MeSH Terms

Conditions

Brain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Maria José López de la Fuente, PhD

    Universidad de Zaragoza

    STUDY CHAIR
  • Jorge Pérez Rey, PhD

    Universidad de Zaragoza

    STUDY CHAIR
  • Naiara Díaz Marín, MSc

    Universidad de Zaragoza

    STUDY CHAIR
  • Javier Mateo Gabás, PhD

    Universidad de Zaragoza

    STUDY CHAIR

Central Study Contacts

Carmen López de la Fuente, PhD

CONTACT

Yolanda Marcén Román, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D. from the University of Zaragoza

Study Record Dates

First Submitted

November 11, 2024

First Posted

November 20, 2024

Study Start

November 29, 2024

Primary Completion

October 31, 2025

Study Completion

December 31, 2025

Last Updated

November 20, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations